688314 康拓医疗
2026/03 - 三个月2025/122024/122023/122022/12

盈利能力分析
净资产收益率 ROE (%)1.81114.58714.45913.35914.463
总资产报酬率 ROA (%)1.44011.91812.42411.49312.494
投入资产回报率 ROIC (%)1.54612.89713.39812.37813.491

边际利润分析
销售毛利率 (%)76.72478.68879.97881.18381.473
营业利润率 (%)19.26231.54632.83633.24535.979
息税前利润/营业总收入 (%)20.17432.98432.13732.12235.255
净利润/营业总收入 (%)17.19027.84227.22127.07930.906

收益指标分析
经营活动净收益/利润总额(%)106.296107.189104.831105.57896.511
价值变动净收益/利润总额(%)-6.784-7.971-11.877-2.0323.904
营业外收支净额/利润总额(%)0.7964.1290.2730.3492.411

偿债能力分析
流动比率 (X)4.3114.2204.4505.3534.614
速动比率 (X)3.9323.9094.1864.9094.171
资产负债率 (%)19.32020.36214.63813.35915.126
带息债务/全部投入资本 (%)9.3209.3515.3725.3746.145
股东权益/带息债务 (%)917.211910.8391,720.0201,729.7301,502.642
股东权益/负债合计 (%)414.323387.728581.101650.424562.775
利息保障倍数 (X)26.622414.795-40.744-25.925-21.854

营运能力分析
应收账款周转天数 (天)18.29712.2318.51712.69011.922
存货周转天数 (天)184.655138.010167.884258.141312.673